- Earnings call transcript Q3 2022

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Ladies and gentlemen, and thank you for standing by. Welcome to the GoodRx Third Quarter 2022 Earnings Call.

As a reminder, today's conference call is being recorded. I will now like to introduce your host for today's call, Whitney Notaro, Vice President of Investor Relations. Please go ahead.

Whitney Notaro

operator. you, Thank and the everyone GoodRx’s conference earnings Good quarter welcome of for third XXXX. call afternoon, to

Joining me our today Co-Founders are Doug Hirsch and Executive and Officer. and Trevor Officers; Karsten Financial Voermann, Chief Co-Chief Bezdek, our

grocer views these results if actual of this obligation those events this from as as statements, report expressed update materially Factors could for and XX, of or indicated Risk our forward-looking statements differ management's statements. we Commission goals fact change. by our the different contain quarter discussed statements. ended results forward-looking opportunity, Factors conditions that such should Any cause impact implied our the subsequent the disclaim on call. forward-looking on call, factors. from and will issue market are but do of materially on XX, the be performance I'd this this XXXX, quarterly to These risks, forward-looking results, statements operation. actual to and and and XX-Q date relate including made our other neither ended forward-looking XX-K to by future important the everyone even considered All remind any of achievements impact cause the year December Exchange XXXX, uncertainties achievements Before our the known our made annual factors our nor to other financial that cause Securities regarding be begin, anticipated guarantees, for business of statements matters any involve to to in These strategies, and on Form call on our performance, not section the on may with objectives, we Form statements or or report statements management's June estimates plans, call results, updated promises like by represent macroeconomic our of future statements, historical of the unknown the performance and filings

which Investor we are earnings addition, In which metrics, GAAP nearest the press non-GAAP in overview our there remind that can like company's accompanying that, be the as to of I'll metric reconciled well. this everyone become and slides, replay release certain may also a found on I'd investors.goodrx.com. page will reference to website the also call of shortly to over turn at Relations available With Doug. it

Doug Hirsch

Americans will by our deliver important Whitney. perspective in go they that to you, we but everyone, and you priorities, most us. of Thank on at and recent thank I afternoon value discussing create hand be two for hand for our price our off shareholders. start Good help to on to which joining as our performance, afford, can we sharing need get a mission Today, the they want healthcare

progress made consumers the more During even of of both engaging with on providers. by furthered particular these our quarter, we deeply all and last in priorities. mission constituents We significant and our with

even provider the made progress shortly, driving touch will talk better this about great we've be retailers on millions pharmacy of of offer their future consumers to for prices, advocates our for and even it over in more We our retail consumer continue forward and we enhanced further easier our worked GoodRx. our contributions have the out decade, the providers to I and ways offerings grow offerings benefit to provider brought network, wanted focused to continued GoodRx build expanded Providers to for content on managers I finding shareholders. toward focused with make look offerings. to value the with to stabilize last platform and but connection first more

million drove better flow $XX.X in own million XX% revenue our adjusted the reaching the expanded the $XXX.X cash Most and and shareholder with which EBITDA we Trevor in our more with expectations expected margin During our pharma third talk exceeded We XQ in quarter provided activities. conversion quarter, shortly. significantly margin. high helped approximately growth, importantly, continued operating we and cash value enhanced all our us stability quarter retailers, ecosystem by deliver manufacturers, than results. of of healthcare about will of providers driving PBMs,

value, Going continue which delivering and also and strong forward, significant to mission. I'll cash now our drive adjusted we actions business. conversion, which growth consumers take EBITDA we over, taken have align helping are further recently is that September, action We launched a focused and our will strengthening efficient while on our driving continued organization. we into and dive mission control the shareholder example some our XXXX. in One of in mission-driven by we've with culture Health, as margins GoodRx

quarter, strong at Health third growth XX%. approximately experienced the year-over-year During GoodRx traffic

and an deeper compelling Additionally, result and registration increases, data chronic transactions consumer as we increasing consumers user more over business in of LTV our on and discussed these proposition areas efforts, ongoing user help with Allowing seeing earnings to leverage the us include to in reminders value information into consumers will to new anticipate their outreach and their with navigate around for we meaningful come. provide We the of provider journey experience. refills. more for prescription quarter create improvements years engage with us second a communications tools other GoodRx the Examples of our healthcare of LTV of as engagement relationships quarters as each prescriptions to are time consumer and we prescription we price through in products QX enhancing benefits early with in even call, efforts better will continue XXXX. our focus stages to allow and to in consumers and which

with prescription for X.X consumer in engagement versus across third significant looking the million quarter. differentials claim serve are promising offerings LTV baseline and efforts and Our usage consumers consumers subscriptions our in transactions consumers. We repeat engaged

services door and finally, to efforts providing an for average the incremental Given see opening transactional has on savings from each extending consumers, our more services, subscription plan X.X array engaged We members. offerings. our of subscribers to approximately engagement

of Importantly, their influence PBMs is retailers, users higher direct behavior, to increasing consumer ability example engagement retailer manufacturers. just prescription and our our benefits ability our An to their leverage fits of needs, especially across and that change us expected as enhances time. more one the ecosystem and to the giving needs best of opportunities over pricing

these provider to consumers, addition we of recent new to last by also our mission help month. our In ways helping providers launch furthering through healthcare mode are

more prescriptions to consumers in these access more and has find much. we solutions mode penetrate over allows because arm the trusted and awareness, to healthcare experience $XX staff they a all been healthcare Over faster, name mindful since play it and need prescribers patients so the $XX flow months, that targeting simply face health providers front office can XXX,XXX of XX launch, their more brand to the prices, prescribing. to overcome get At access the HCPs, of time access firsthand consequences including last savings see tools spend shows by offers they fill up the our focusing moment of billion they affordably. used and GoodRx their help last addressing to pivotal $XX to point providers providers medical develop when as to but the examples. have discounts, the patient look of hands us by customized providers on medication who it a to complements the patients patients, target spent information assistants challenges. embraced on and choose or expanded role care This pharma not in in too In TAM $XX with GoodRx prescription prescription costs nurses, better at affordability information product medication through manufacturer We is prescriptions patients help would need wanted helping billion more behalf of Provider they data a care. to the more HCPs that decade, approximately billion and strategy consumers, billion, growth redesigned adherence, the of

started to broader of our the on for provider becoming since pharma seen provider seen progress out I time Early providers a received we we've extremely mode feedback from gives the work to and has unique in remarkable positive. is manufacturers can't Provider largest providers. last have mode since in one went launch addition, our often thank team, December, specifically achievement a and their the almost us offering This integrations been GoodRx designed also rate XX% the with it recent short In path the opportunity live. strategic hard U.S. for enough has them partners develop that the putting it platforms rolling by

of price hub. to we're updates to with helps pages. who reinforce it ongoing millions is For team furthering mode for a we're more example, have we of recently we to mission a easier on make very it patients in mission the relapsing revenue the driving providing taking sclerosis and users improve actions will commitment in quarters to how you with call We Biogen the plan and specialty Trevor more is clinical our of on forward anticipate now we The and and that of come. our adding months, a outcomes, and with the for top world-class Americans provider aligned coming consumer to heading decided to this shareholder value. driving health will how to VUMERITYto provider onto multiple drug EHR details I make a where LTV relationships look information collaboration HCPs the to increases that in accessible also our forms their new start about platform forward. result the patients announced on as going excited We're turn enroll over

Trevor Bezdek

afternoon Doug, you, Thank and everyone. good

strength the quarter Before ecosystem. about into of our manufacturer talk our as increasing to going retail, relationships I'm well pharma third PBM of broader as getting and results, our health the

areas was network, there. One interest begin main of earnings on quarter of our so second our the call I'll investor retail

pharmacy's call we've discussed earnings issue we in during have been point as discounts since addressed welcomed at and grocer grocer sale. that the GoodRx Importantly, the of August,

year-over-year With X% grocer, the approximately and particular across quarter-over-quarter. exception increased volume pharmacies approximately X% other this of

network, and our been environment our with to contractual relationships Today, direct pharmacies with pharmacies relationships to our believe contracting challenges selective new have relationships. success more stronger With us and agreements the our gold provided contractual and our strategic proactively tied approach on more relationships our and to over drive PBMs We're with success profitability. relationships model are solutions PBMs strategy improve control with existing retailers economics while communication retailers existing and with We and happy by complement deepen our discussed our share involves These Historically, of own growth insights PBM the to all our current continue drive direct consumers their Giant presented of strength knowing ensures believe Doug strongly more retailers. and regard with mutual macro retailers. extension strengthening their with elements bring the Eagle. maintaining acquiring continued to our retail interdependent. and with us economics. our contractual helping of hybrid initiatives and has We business I’m better. We key pharmacies. unit have our addition our their initiatives of new will stronger enable unique provide network the business The the consumers the even of to of strengthen retail Through customers. that efficiently model into the approach to lines on collaborate agreements our and agreements

value agreed that GoodRx GoodRx XX% recall found pharmacy want return may users their over that them across merchandiser pharmacy a their pharmacy of of when survey reported consumers general just are that These groceries conducted of additional positive network. more our or that X,XXX Gold also experience purchase retail items an we a with on non-prescription preferred up at $XX prescription, often. survey makes pharmacies some to GoodRx of they The at adds how the and XX% found more that to examples You picking such almost that surveyed average spending counter. XXXX as consumers GoodRx to

terminate PBM GoodRx. strong and retail PBMs addition and partnerships PBM we never of our relationship have had This we efficiently partners. continue relationships, to our we volume network robust our the In strong of its have with result and is drive the for value with a to

that eligible members. revenue collaboration a about as Additionally, them this instances price to Express we and eligible PBM members is in automatically Under generic Express transactions make of will prices are for This leveraging innovative drive program, especially benefit in where new their group medication access seamless to their more support means we acquisition part are their affordable efficient Express An in new GoodRx member eligible pharmacy excited price. our prices will benefit. prescription lower their Scripts have ways. GoodRx relationships user an access than Scripts with medicines is prescription to mission example, for to

innovative the We pharmacy out-of-pocket selected keeps this program. to Importantly, Express order enables eligible account visibility were new and members the trust is this strong last claims claims the of for be consumers powered delighted have technology a leadership in partner RxNXT. Scripts’ believe it collaboration our exclusive of within the deep of and benefit, the prescription of by GoodRx brand as strength this year's space, discount We members our validation our acquisition deductible. important in

we prescription we accepted that to users. collaboration U.S. that opportunity pharmacies discount a to XX% offering This early new Scripts’ Express the on and many believe offerings become way top the creates anticipated cash this efficiently time market that expands than represents beat Next, clients more commercial XXXX. in and XX our other of distribution Today, based incremental expansive new drugs space, channel analysis. to U.S. in have available most most is gain the PBM the in our in our the on prices relationships of network a

continue solutions deliver more those and offer We more work. with pharma to we manufacturers, ROIs which with work to superior

solutions patients healthcare made of suite up as for searches a millions of visitors both and way providers, effective providers, our are brand as on of consumers four pharma drugs. reach to leveraging that Our highly platform creates the compelling of well XX% our approximately manufacturers monthly and

top shifting to these shows bottom the on drug traffic, because medications have present the giving with own to high TAM to complicated medications, tend billion runway. is spending, offering. yet life prescription intent consumers spend saving even and to the part ability for of so consumers penetrated pharma the GoodRx is brands and insurance adherence, XXX we is us these providers they with improve in traffic with affordable to use a encourage to manufacturer to that impact outcomes. HCPs fact, who branded to remember or and we near-term coverage not this we through ROI this moderation brands when drug The in GoodRx gain through more approximately effectively manufacturers unique huge, LTV manufacturers their That massive spend the adherence. in our medication, products Pharma but the attractive is provide to In our at to providers, and awareness, important services, are healthcare our of restrictive. drug to they by started generic use help of page want access and in of has market and and annually the better options, be increasing It savings same and results to which driving the users increasing reach and patients achieve funnel set hand. challenges their multiple solutions even may target struggled saving industry some of $XX face also and analysis among said, a pages access help the billion with to a X% challenges digital branded and our are that offerings, directly address $XX compared partner so as often they our and often with expensive With awareness able and innovate to

with our with continue to customers, growth experience monitor strategic be Other we'll While the solid to growth we our to landscape and perform continue initiatives proactive well. continue strategy.

capabilities. believe vitaCare's improve which decided experience it control, gives medication journey elements and be differentiation, our across can and much our another have provider initiating capabilities how EBITDA, we recent complex well. mode exciting of to acquisition HCPs is That is the of integration We offerings. providers where specialty prescription the a aims an vitaCare to access We manufacturers about at key and patient therapy. to brand On patients pharma to our providers all journey, enrollment announcement and a now I to Doug, the medication send all increases patient pharma to expenses and adherence spend innovative through therapy. example part adjusted help to the we An pharmacy the utilize HCP focus with our focused which exactly talked I who of we collaboration done. start us the from patient and drive and can to our is valuable relates also when the most for second access Karsten On and strength VUMERITY start about this to service continue vitaCare earnings which and patients platform particularly revenue. hub, product Biogen, on therapy. talked have yet work the innovative enhances to specialty as which front, information of their on call, manufacturers new and with to finish of process of to helps reprioritizing our facilitate taking going and and patients directly navigate quarter focus hard costs what a and business our look volume

review a effectively in we expansion. to August The believe Following more cost our to investments of was we efficient and rebalance reduction growth will careful that realignment margin we in and business part operate an our structure, prioritize announced initiatives structure our organizational of into efficiently. resulting force implemented drive areas and

cash our value addressable expand proposition. customer flow for are on strengthening from growth established current our new our into We seeds faster in while areas planting platforms, to business focused generation optimizing efficiently by markets

of expectation EBITDA $XX was approximately expected dollars Adjusted adjusted begin actions. for more was than $XXX XX%, on the was to was and which this approximately our million approximately million adjusted implied EBITDA XX% margin. quarter the of our revenue exceeded Total million, $XX Our these results quarter EBITDA which margin benefits third $XXX.X reflect million.

continue million XXXX, even efficiency ahead third as points of $X.X XXXX, The at also of the third $XX.X consumers by at across from in reduction between earned we million and second million XXXX. third still driven XXXX, end this serve million the with completed continued under new sales the the $XXX.X quarter. marketing of from transactions $XXX.X full focusing revenue associated percentage five count offerings, and many force consistent amount EBITDA prescription advertising consumers million subscriptions and decreased while and begin grocer math transactions marketing The from XX% of to plan last was of impact The of to marketing partly the transactions our issue. million Relative proportion to years change which in the connection despite the to of revenue relatively millions health $XX.X quarter outperformance deductibles. year-end a in quarter around grocer by and XX% one-time fell first advertising plan remained to and We well $X.X prescription make the the we by second quarter grocer as million the plans million in XX% investments $XX.X of and in part our as the $X.X the quarter quarter fresh with to dropped is during totaled $XX.X to million. period adjusted from we by decreased the prescription when well of on with

approximately million, we been and by provided revenue this on XX% flow $XX.X cash activities strong was have metric. representing Our operating of consistently

our efficiently consistently growth from delivering that, come have adjusted on EBITDA investments over consumers going forward growing expect profitable to what results guidance. With to while focused and they to needed quarter-over-quarter I'll GoodRx. and Karsten highly to is financial they're only highly where it by drive team reprioritizing to turn discuss Our

Karsten Voermann

the quarterly business for also which transactions we with in how Total of ongoing the retailers Thank our decreased quarter which and above $XXX.X million, as XX% revenue. to X% can you, $XXX Prescription our dialogue decreased continues revenue million. drive further year-over-year been have revenue Trevor. guidance exceeded positive year-over-year, came and expectations reviews

the as approximately particular that $X.X the volume shift impacted result PTR declined per X% over in quarter. exception X% other MAC the decrease year-over-year of year-over-year by retailers and increased and efforts grocer transactions of PTR an X% to million, driven was quarter MAC to XX% of with while and other pricing previously we ongoing a consumer X% across in engagement that impact decrease The quarter-over-quarter. and discussed. the year-over-year Importantly, decreased prescription MAC pharmacies grocer volume

in quarter positive We growth at week-over-week also experienced positive end time quarter, grocer we the the first the which saw the growth. since first week-over-week was the of

be engagement. We and growth, focused consumer user continue to on pricing

On expected. the the we engagement than was conversion the third in on quarter impact front, less

and out Trevor beyond. roll on, continue touched Doug and our engagement fourth As in the to we’ll efforts quarter

subscriber down the ended XX% year-over-year, Kroger Subscription a subscription benefited churn quarter. reduced benefit some subscriptions. spend. with Savings subscription do expected fourth our total in in increasing revenue million XXXX X% X.X saw members our expectations. We continued plans, but our our improvement the and offsetting increase offering in we half decline the to in decreases primarily result increase Gold resulting remains we an year-over-year, slightly expected churn, during count and the as of Turning exceeding account, from fee family our which strong, quarter The X.X quarter. and churn from is meaningful in in plans first the memberships million due subscriptions was to subscription taking for anticipate When of decline a from September into the subscriptions fee sequential marketing

third across our have transactions As X.X million we’re subscriptions served to the offerings. quarter Trevor and said, in consumers prescription proud

the Pharma less we Our a in than which of started temporary control expect see be to to we in degree XX% increased industry quarter, nature. Manufacturer revenue Solutions the year-over-year, expense anticipated

superior ROIs quarter million delivering second is which those to pharma is pleased integration work. how continue we and more We to revenue with contributed the approximately of working contribution and of the we offering progressing. solutions which $X related are more This manufacturers of are with vitaCare,

our $XX.X flat primarily force, revenue of last or $XX.X Other the or related of organization XXXX, Solutions XXXX. the nine $XX.X expectations. the in also first increased We’re XX% Cost nine Pharma support or which in pleased was X% comparable to Manufacturer of slightly our future and was of revenue our increased related driven head first scale. efforts and our realignment XX% revenue higher XX% million relative investment of and align in that due in goals greater period products $X.X from costs to expenses to in reprioritization costs our higher strategic that million goals technology capitalization of personnel substantially to of compared ahead from to revenue to our offset the revenue strategic at relatively XQ revenue months million in-period X% million of related acquisition in consumer driven of by and in primarily development year, in development software of remained reduction months vitaCare. resulting $XX.X by to XX% million XXXX, of the with increase an compared count allocated better and development of Product the to overhead resulting by of support revenue

in revenue XX% expense XQ items, and revenue relatively product. was of compensation to in XXXX. or Sales Adjusted compared XX% increase were XX% million Excluding adjusted marketing or development of $XX.X product revenue expenses to team due of technology stock-based million other and were technology and and investments development quarter-over-quarter. also $XX.X The to flat expenses in product XQ compared XXXX. was the revenue expense of XX%

As investments the our in and team balance we efficiently. look more GoodRx to build brand

marketing or to items, quarter the grocer on in consistent. a down a of our by $XX.X other Despite by offset related counts pleased issue expenses partially higher administrative XQ have of compared the sales focus year-over-year vitaCare General contingent consideration efficiency. quarter-over-quarter, and related relative that The or in head in in third MAC and impact change larger due XXXX. fair expenses primarily the of stock-based expense driven to X% acquisition spend to XX% and XX% down marketing count, a second an adjusted was reductions million and and $XX.X and were value decrease we’re the quarter, revenue remained the stock-based expense. increase due to and payroll expense compensation Excluding revenue XX% $XX.X of million in the million is increase to compensation

is as adjustments, year-over-year and grocer as adjusted and which to to compared compensation as revenue. expense change administrative these grocer revenue the growth percentage as largely impacted XQ has XXXX. in million, of million. The stock-based materially to to other to and in well decreased a a $XX earlier, a of to XX% Adjusted impacted an acquisition vitaCare year-over-year general the adjusted the administrative $XX.X contributed and Excluding percentage revenue. grocer X% revenue $XX.X EBITDA compared driven expense by adjusted decrease G&A related issue, contingent costs X% $XX.X marketing expense issue issue net by a and in operating increase expenses a expense of percentage in fair by was Net a and partially consideration in sales value XXXX. related increase Adjusted described offset income of the million loss million in of the Net XX% loss XQ and expenses. decreased general loss to as net

one-time we’ll time focus marketing invest losses stated of in the on offerings generation efficiency. cash strong operating of and to XQ continue our by for million we provided August during in to cash provided EBITDA, but to net as acquisition the generated come. Adjusted which activities in declined the will exceeded of historically focus such we the in generated and net continue also in the reduction-in-force $XX.X the points and quarter quarter, adjusted our on improved EBITDA We We as at flow we near-term. completed adjusted vitaCare, XXX quarter-over-quarter year-over-year, expect given we which basis EBITDA quarters has margin continue negative approximately growing new guidance and the XX%

million Class $XXX QX, of had repurchased stock Board common shares. approximately purchase first At X.X our during $XXX.X remaining A by our During million we from QX, the quarter. million share of approved million we the authorization $XX end or

$XXX.X ongoing a million I cash sheet also cash as maintains allocation third uncertainty the end strong and priorities. had the Given around in balance position. of GoodRx the talk outstanding in equivalents balance a million our $XXX.X our and sheet net economy, about We sheet debt wanted balance capital the with and quarter. the on cash to of

priorities support business, also returning strong to maintaining furthering to and and value. opportunities challenges sheet, strategy. reinvesting a near-term that allocation linked and creating the two are evaluating capital directly company’s Our support strategy GoodRx’s flexibility to providing balance priorities, most growth shareholders navigate while acquisition mission in our important are capital share the our purchases long-term These via shareholder

guidance. onto Moving

revenue $XX of fourth quarter, we approximately million efforts. a grocer related consumer estimated which and impact For million assumes combined expect transactions to $XX to prescription the million, our engagement $XXX the million issue $XXX to

the We year-over-year full expect of grocer first seeing XXXX, the to of the which XXXX impact impact the we with until quarter when left disruption. XQ XQ was issue continue

Our to a to volume. MAC time, decrease expectation until primarily modestly continue to due PTR retailer that an shift quarter-over-quarter is per for ongoing in

subscription approximately million revenue expect of to million $XX $XX down We quarter-over-quarter.

quarter to subscribers we a anticipated, to smaller new the out Gold entering year. As existing fourth prices due we the and with base increased half the we’re churn the first subscriber during expected related to of rolled

in is narrower the audience, this As anticipated focuses second strategic of the longer-term. on offering to growth repositioning churn which the quarter on negatively impacts our reduce rates, we but mentioned earnings call,

of the As increases half took benefit the first quarter. the to during and are a incremental not fourth reminder, place price the providing year

which user’s fourth effects pricing subscriber lag on churn their from the changed, impact the counts does However, quarter. time

by XX%. approximately Solutions Manufacturer grow Pharma to expect quarter-over-quarter We

a Pharma favorite Solutions be CFO, to Manufacturer As offering. GoodRx my continues

HealthiNation and volatility. we’ve large, on multimillion this comprises to can shifts that The about their more the such fundamentally trajectory. barely optimistic our outreach offering healthcare side deal relatively deals and billion TAM highly often macro we assets $XX dollar previously, acquired consumer discussed the as driving However, our consumption, video in to digital tail end create multi-year we penetrated, the making huge quarterly staff providers content as

Finally, we to million third million other with expect we total the to $XXX in million $X $XXX expect be consistent or revenue approximately approximately quarter. of aggregate, revenue fourth quarter In the $X million.

the And our third primarily our quarter, provided Prescription in into the user and margin function The to to marketing, expectations efforts the maintaining opportune engagement mentioned, low relative relates do business be so. can to the XX% we We mid year-end expect time quarter so an second decline call. in EBITDA our we’re adjusted I on anticipated is invest margin modest consistent is which as flexibility to range. earnings to decline Transactions the fall revenue a to of with

Finally, as articulated vitaCare will time the as continue few since EBITDA have more the we adjusted vitaCare’s to likely margins, acquisition, of we’ve a drag to our for a on case quarters. expect be

on strategy and focusing strong to on cash to focus performance consistent return to and and conversion. the on growth we EBITDA right place continues We have growing margin Our be believe adjusted high are in to margin continuing deliver efficient remarks. investments organic Trevor progress and With for quarters it long-term. our the for the that forward closing growth strengthen in will I’ll turn you drive to over to this updating look I platforms that, ahead.

Trevor Bezdek

We the recognizing we excited about are future challenges and near-term ahead, the our opportunities face. also while

EBITDA, profitability which measured is as leadership team committed one by continue improving as to number adjusted our our on challenges. we goal. view focus Our these to navigating We’ll

on the began in initiatives the growth also reduction to following cost our reaccelerating manner platform in efficient are an we third quarter. by We expand focused leveraging margins revenue

fast We over from expect platform. long-term benefits with see our investing Solutions Manufacturer Pharma to in along on engagement the our focus efforts, meaningful growing our

us ability turn profitable joining Q&A. our help are operator mission as to in you today. again while need the to We continue on they now the deliver they to Americans to our returning can growth, we high confident get a achieve it price remaining goals healthcare Thank at for over I’ll afford. our for of to highly

Operator

for moment line comes moment line is your for next open. our and first [Operator Hill, from go Please George One Hill ahead, the question, with it please. Instructions] One of DB. Mr. our question,

with next of from comes Truist. proceed. Jailendra the question Please Singh Our line

Jailendra Singh

Thanks and are you know thanks puts I year issue keep for but see taking grocer headwind and willing to at guidance next year. share And is XXXX this you my share basis. are year-over-year we questions. some not much guys on in point, a for Of visibly you this one point? factors at some on at those for how next have puts takes you course, point? and mind takes additional maybe should But do this providing

Karsten Voermann

of the visibility, as again. Yes, Sure. to we speaking. hear do course. This you, I from is Jailendra. Great Karsten have XXXX question, some Thanks think we into look for

penetrated I think like from prescription barely a into the transactions biggest confidence one. TAM, still areas feel that come we of we’re the number reality

Our also we’re Manufacturer where large, very and Solutions penetrated. market TAM is lightly also

particular that two those ones in focused so are And tailwinds on. we are highly

around think manufacturers to somewhat spend the longer spend make into Solutions, period pharma on taking period quarter, marketplace being extend and decisions the with interim seeing XXXX the well. in going on which focused how I more given in fourth what could though, respect particularly with as marketing Manufacturer and to in we’re

to year will we continue beginning continue to refine on monitor between of will We how at upcoming XXXX earning that to when our our evolve. and now situation call the do reviews the

Operator

for It of Michael our line question, please. the moment comes with America. of next from One Bank Cherny

Your question, please.

Michael Cherny

Obviously into as to it I Good the on important dive potential – Congratulations the evening. both just to to little in how love but progression get relative Can relationship with it a of to a us fruition trying should to about this And ramps of to for revenue, maybe we really on with. on b, guidance, through on first I’d Scripts taking the give beyond result incremental this through Thanks the expand brand a work and very question. bit exclusive. again, how in and how talked start PBM ahead noticed filter for a see XXXX the to for announcement. sense nice not you to came up. terms term then quarter. you think Express costs name potential

Doug Hirsch

question. the for Michael you, Thank

with new members. We’re medicines helps part support this their for make Express their It Express prices get this affordable benefit. Script pharmacy to prescription to Under access as pleased GoodRx us collaboration new eligible program members about Scripts. more mission their really of

this market Express This claim of discount prescription year’s brand an good recognition It and of the by in of as of generic strength when for is brought our the space in of benefit. trust benefit member Scripts gives our the GoodRx visibility within of eligible of GoodRx have full leadership their really believe technology. it’s we’re acquisition and creates is pocket the the The were last consumers new collaboration So the delighted a selected the claims enables the And claim RxNXT. member this technology this powered a pharmacy we access distribution commercial than gain represents you to users. is to to many GoodRx Script to eligible price It keeps anticipated efficiently visibility channel to expands prices for We the new program. eligible early price. the available medication Scripts believe count later lower And and seamless toward gets incremental way an out payer, just partner up, for as the a We that deductible, be offering this XXXX. of that exclusive Express clients us. to opportunity. Express year member’s

Operator

question. One next with you. comes our Sachs. moment Goldman for go from Please ahead. Sheridan Thank It Eric

Eric Sheridan

Thanks to the on so hone bit little taking of a for question. I much the other of want in revenue. some drivers

some as with conversations next platform? as as continuing evidence you for companies. terms to solutions talked of see continued so XXXX and outcomes those lot ROI for marketers evolve We’ve a platform into to the drive more on for into and dynamic much. and a out year. supportive budget of like industry move outcomes to them healthcare Thanks of could high drive this marketing of you good out XXXX you How what coming of side and about and the going on In and year the working closely

Karsten Voermann

think points there, in really manufacturers. the critical are great in the here. very excited context, speaking Manufacturer think we the in you’re we Karsten in serve the I other few revenues Yes, I as which question. for that component characterized is that what about line of business you Solutions particular think I are pharma it, here. biggest considering And there This Thanks our are

that very The the prices, for $XX their It’s split of TAM, to used discounts, from about perspective first huge. the very the those continues And providers parts that and to last hit both billion $XX TAM we prescribers so that consumers. to healthcare effectively million TAM cetera, at et patients. prescription to behalf to attractive $XX XX point of GoodRx is manufacturers, us. is of million business alone, have look medication months on In XXX,XXX be our

So from we remain perspective, highly that bullish.

think being us both both lot receptive we with provider of I front manufacturers. the of by XX and the consumer with and sets being to create mean served addition, for The constituencies are have pharma on providers the with NPS and in us. a to value hardly approached respect relationships consumers

which their deep a visitors providers savings for a mentioned on folks directly patients tens GoodRx visitors the that monthly medication all layered to, the funnel as example sharing be manufacturers When are is opportunity we rapidly which to discounts allows significant it. without very share personal number a have, number. platforms, their very are for in you think tool again, also in those who for come of prepared to or tend with email provider looking the mode, also or actually phone pharma particular We’ve address whom of the that in We remarks, as Trevor of all GoodRx’s Trevor benefit in visitors because in said, volume. particular millions,

on indeed. with build these basis use sticky new of very, that in their are patients So infrastructure recurring kinds tools a interactions that very providers

elements pharma over those on of together our to the meaning of all manufacturer business. quarters longer to sort allow couple solutions think bullish term, to I So, us medium continue incredibly

I has one scripted are to remarks very pharma the grew first solutions sustained. said, year around year at longer the pharma well, the the as business will think interim manufacturer time year and when business period looked over when in into in example, we period alluded right at nine any given as be spend decisions of like now, to manufacturers end to that like business last more our think the make over months at in particular can taking specific at or fluctuation I of term with deals that catalyzes period first time, longer compared XX% pleased end. around nine the specific $XX growth in some this come any any millions the of tens that size, have causes of a that that level in rates – around amounting challenges even millions to That year – to we’ve months And the potential significant us that’s millions for that and things predicting one of looked of dollars quarter. the been a time, in sometimes quite deal,

Operator

please. JPMorgan. One next Thank Please And Doug comes with it question the for our of from moment Anmuth line you. proceed.

Doug Anmuth

revenue have Thanks functioning, how welcomed of for ground, [indiscernible]. were more the compelling Thanks. on had over that’s question. can large discounts issue less us taking to grocer, now less kind And data having prices playing now. With you again start loss help you in out understand the just traffic, the foot

Doug Hirsch

It Kroger best you, grocer you, of as that been little my Thank GoodRx do each sale. have question. the Pharmacy’s of welcomed August, I’ll so we’ve to was touch at to on part was to discounts Doug. hear discussed, hard a issue in since point addressed But

During pleased third see, particular are we quarter, increase volumes grocer, the that of to the quarter-over-quarter. did with X% exception

direct topics in prepared more we’ve relationships remarks how really the in and these as really disruption, for we Kroger, are we now Club. increases headway on we week-over-week front volume think did step seeing the these this strengthening of that we retail down network. increases that Kroger made happy volume why that’s also that as a good – of this are Savings made are at up because with We in in And the in brought have have subscribers well retailers. We we period

But maintain many That and stability, in direct We really chains. us have the direct to drive including sure to to make anticipate ensure – don’t enable partly, collaborate on strong our and marketplace. really success. lets contracting solutions model we pharmacies addition, selectively the PBM of because issue. we having continued any us anticipate we relationships are to – largest Because hybrid network we have don’t these want we with similar

allow marketing there just and partnerships, have We stickier also and think us of this direct deeper relationships to opportunities relationships, a incremental – variety allows are be there. these deeper

Operator

for Thank ahead. with question, Please Davis our go moment SVB from Stephanie Securities. please. you. One next It comes

Stephanie Davis

and light ask remarks my thank greater I press the on release a focus, little question. just to profitability really the you taking a for new focus about conversion. in guys, want of prepared to cash Hey bit both point

could on step a a up step areas back lines just So, could light bit of and you early investments through that conversely walk that merit focus? could that us thoughts your in of business merit in

Karsten Voermann

going on speaking, that take Karsten this on forward. because start, it. One’s I really focus focus is EBITDA to can of is Stephanie, other I may see think others and opportunities growth in flow There are two for and and they the the jump through Sure, here. parts cash, the

focusing So you part on question the first heard correctly. of quite yes, the initially, us

revenue reality that with earnings quarter we’d earnings call at where said particularly second that during think as more careful I don’t August growth. really was And of operate and review And trade realigned business the on is elements, cash are undertook largely a that and felt effectively I efficiency, our that the our do as that at even and we our conversion focus we of as comments These growth conversion we like on also the in manifestation on we the a particular our risk and focus took and you allowed end the our focusing point EBITDA too. structure refocusing organization us to leaders to consistent entire efficiently and across of organization think the well its already and is a by control. cash prioritization really involved mentioned. off amount key well. We looking of greater in forward significant

even cut line new sales marketing about a we impactful. for the like stable despite that’s at as like we’re seen you also And you’ve to remain MAC when further of those issue back as counts still us You which sure example, things grocer look provider marketing the terms as look highly an absolute I’m revenue dollar see MAC counts percent successfully and Q&A we’ll able mode, at offerings creating when then well. and talk and

quite scale efficiently savings already our of the effectively, what than I we’ve still certainly can brand the faces in reality combined and be we strength subscriptions, to. such operate, we grow but that used to and transactions player prescription more fact offerings is to that of built leverage built mean as also think able the we we’re the that we’ve the the many

going In And team terms start, of in particularly areas jump forward, the I’ll in solutions multi about bullish manufacturers well. past, we sort we’ve others as sure pharma the of talked over quarter incredibly growth evolution. but I’m on will as remain on a

an of benefits to quarters, the reports think be can penetration I the which to which today. be in incredibly course plus fluctuation, recent quarter over the And business. into business were it given towards low us multiple shift manufacturer interviews relatively that attractive next sell of indicate size up that only have of The continue for digital, TAM, also but be some sheer that any that only digital very, come example, manufacturers continues bullish in of us will go where pharma the year pharma solutions into to very out spend encourage from shift will into offering next and broader the year across side the particular.

Doug Hirsch

is some tightly. and about jump our the more with this and we’re about a bit as of Doug, both things excited physicians with regard engaging talk more I’ll And in our, well little as consumers to

aspects users to their to baseline. We healthcare that their for all their best can just prescriptions. price we’re know As allows and fits engaged leverage And play versus our their to the provider Really and communicate more When can we higher needs consumers reminders set usage of retailer data tools. and role user relationship, to for respond improvements we deepen active our GoodRx we create client of LTV better, at much to can refills. the and when we pharmacy repeat not our anticipate us seeing consumers products or counter. engage allows it our better, needs. We our their guide in with care, know claim prescription new us more a it pharmacy for to

medicine we’ve rolled and recently For out I’m example, very, cabinet very which about. the [ph], excited

all as punch our prescription well subscription of the mentioned. like this and offerings, ARPU core both the our from Karsten result really the anticipate a of value also as and solutions line and manufacturer related businesses, increasing is each therefore pharma the As our that associated we to with users

Operator

moment for One of please. from It comes next proceed. Please you. Thank our the question Hettenbach Morgan Craig Stanley. line with

Craig Hettenbach

thanks. Yes,

or pharma pharma? manufacturing statistics us in penetration on on, related update back any with following Or TAM, can whether anecdotes particularly Just share there it’s the your are to just top XX you any terms solutions kind just of a had also today? stands utilization the business, just kind were of October? question end through business you prescription that trends of what the And where seeing core for quick on of then the

Karsten Voermann

Sure.

So, questions I embedded think couple of sort there.

of First I’ll solutions Karsten is again; tackle manufacturer all, this part. the speaking

before, quite said top well that by pharma we’ve fact, we top opportunity XX as we’re we’re continue business, our XX as while to penetrated bit. the see grow of grow in to in XX those significant on manufacturers, into top as deeply the to today, a beyond top So relationships

at number the of So number of of about and the top drive of different XX, of to XX GoodRx. first the relationships are and opportunities we’re overtime. in advantage offering number those the we’ve volume brands manufacturers of medications manufacturer top of grow expand excited deepening that the help the they’re progress those lens, to all, on made to context of while the those we opportunities been we’ve taking top we’re And continue each the using expand in serve number from we in solutions solutions to able and

to to acquisition us in From cycle. provider moment allows vitaCare, fact, into in the also the and through vitaCare when for because that really almost the ties the step the be particularly the it that the did we consumers year a writes prescription around things that at actually preauthorization exists, like. earlier complexity entirety the of including the and on offering involved an the prescription In therapies from pharmacy, is receiving insured the period healthcare the like lot of patients managing benefiting

these in of U.S. So XX very deeply manufacturers manufacturers call XX% our penetrated secondly, become approximately the more Then high. ability period. it or with to we’re into involved XX% top

as manufacturers amazing So to more of well. ahead amount us an there’s into runway of penetrate still

we’re growth that about vector. So, excited

we’ve And we of that basis, time particular. the of evolution the call closely business, about on dimension, I that at the is in think about the follow particularly the very solutions past, one season opportunity flu more talked medications. excited to that week-to-week, With about incremental penetrate the year excited in of a it respect into the to we’re We’re transactions factors this month-to-month also in prescription vector.

flu us well. for of all correlate as individuals on more as tough it’s While aggressive with tailwinds to GoodRx seasons tend

on help is able largely are that GoodRx to of healthcare that set utilization utilization monitoring well And of we’re closely. reason as much earnings consumer largest had normal, those So, situation as own the call, I of patients. providers promote are in healthcare a of potentially of the the who that too behalf matter talked big growth. their to is return so the we’ve to and for on on to we that are healthcare GoodRx the interactions the a healthcare flu little our community the first as for driver key And evangelists us one broadly us dimensions is with but early that reasons about one great groups last broadly, closely front, the which front, both predict, think seen it’s

have to GoodRx us offices over they promote XXX,XXX in solicit better and their so patients We patients from that GoodRx doctors’ outcomes. that can related result collaterals

like back around even the COVID era into quarters going healthcare dynamics to leverage And normal tools having can those to year that sort mode same provider thing utilization, created providers more expect GoodRx of We be we XXXX. middle bigger also and this do forward under utilization tailwinds evolve returned from to bigger the the things more efficiently. exactly the of so as

Operator

moment One question. with from line our you. Yong And of comes the Please proceed. Suisse. Thank for next Jonathan it Credit

Jonathan Yong

Hey, thanks for question. my taking

was XQ, XQ guide, grocer. improvement Just that then a I on that week-on-week improvement sequential guiding a on the grocer you’re that $XX basis. mentioning impact million little if for but also But you’re you’re from estimating seeing at essentially look the headwind, your particular for impact, you’re

is gap the improvement, into closes and we XXXX So, a me commentary your as reconcile XXXX? alongside this should this help And the that function guide and can deeper on and million move think $XX that, end? your on Thanks. you conservatism into of we

Karsten Voermann

Yes. Sure.

of question by and first me – commentary. all your the beginning of Let the with bridging start

million the $XX impact we’re that’s for different function of quarter last couple roughly anticipating forward a things. the about impact going a talked grocer we size similar and while So in a

I relative to what used think week-on-week the first small The base is growth be. often with associated it that, to grocer. well are week-on-week the is extraordinarily we some seeing growth

having XX% – XX% the just very revenue as if So, percentage with aggregate when that with you low the lower forgotten grocer even today grocer. represented are amount number of approximately the the really of to we’ve associated that look doesn’t where impact dollar of growing the much it’s at slightly, in historically volume, today of shy number revenue they single-digits,

XX%. have at, it’s a a small revenue shy impact I levels today, on grocers with scale relative again, significant though the So said, like of gap doesn’t association in even to that’s growing just historical left the our of contribution

forward that there will to are gap whether of of how question, the could which think your other and part I couple think articulate. dynamics I to goes going evolve to the close? a

pricing while is GoodRx that the don’t is think to at any we we we’re that and expect the first I important levels anywhere historical we’re that close country. of same the the of The think the availability it’s ubiquity have for that a the ones. the grocer across GoodRx, many return marketplace, that of nearly to At other volume a with was about large the see that, excited of reality can XX%-ish don’t that pharmacies lowest of our time, we And relative the grocer to of the users to use momentum price, about advantaged excited that Meaning you that’s which the highly And function be retailers. a went at given to used XX% we’re revenue. grocer reality and grocer. including volume we particular because to that few factors, see a of of

close is low the that not of often pharmacy, think they’re lowest total market volume see that pharmacy historical to I we anywhere in at that price the the particular to return anymore, of unlikely Now, single-digits levels represents the volume historically. them market don’t getting to was perspective. expect see wouldn’t going And share hope I helpful? a big a as that’s as think I to from it whole Therefore, over share close the as it index forward. we anywhere

Operator

And Lee ISI. Evercore from Young with the One it moment next for Please [ph] our please. proceed. of question comes line

Unidentified Analyst

you. pharma just timing to thank Great, have a solution questions. I couple the push-out. One, clarify on comment of deal

overall on to initiatives? and you. letter that you expect Or And a is rather that think kind it become Thank Just just in see I do pharmaceuticals? Because million like, when than front you headwind? from that clarify, push-out And of also much from a you in to an spend the the marketing to timing? in of as do engagement a million $XX second $XX the to the the is be tailwind expect do that’s mentioned customer QX, of in how pullback well.

Doug Hirsch

Thanks Jang. the questions great Sure. for

mean is I’ve on side pharma out studies is that grow over access expected That’s, read single-digits the broadly to and think the So next indicate be of based market To advertising, as in awareness putting is level rapidly couple the mid before growing the direction is first it our market to and that’s us to I whole the to I to latest I the on adherence interviews of probably GoodRx, last growth. broadly and general it. spend in that and all a timing And questions came view speaking what the year. take medication that that for an revenue weeks market that continues solutions best solutions itself of one more way by us. at attractive and quantum of that single-digit getting attractive the sell specific in the very mid manufacturer the think around pharma

and and what to be pharma digital to unique GoodRx’s think to particularly healthcare is providers more continuing to manufacturers specific are consumers that both makes indicating relatively able healthcare ability years, providers target benefit, shift it to the attractive in to and I they’re given to a in that shift even way. continued target our make, consumers very to digital be because committed

able is as reap from in that healthcare we’ve So example, making the as of the provider offering our investments well solutions. related one buy benefits providers provider to we’re which been mode specialty, for healthcare

it timing as in GoodRx’s potentially market as shift I we questionable see is but through So the one overall being now higher it than in even the the the surveys the of ever dimensions, the may high was, recent two we’re those more past, digital I to with which attractiveness think in think reality confirmed, was seeing. continued be for

positive So a this again, over we and business view. remained very multi I quarter on very think bullish

question, think consumer engagement the to consumer respect second of quarter. your I to with related more in question part specifically engagement think of and part the your of that I the impacts fourth

around engagement So of efforts third mid the quarter consumer launched quarter. the

we the last quarter quarter. expect And million around saw expected see or see half the So, only about $X in somewhere to of we’d impact we to said impact. fourth we

I reality that. think the than was little better a

partial to as with the so efforts prior the continue I think attenuation quarter where for course. going cause with impact narrowing of to call. beyond again, this And We’re these intend year bit, a this full the impact funnel also quarter, for pleased consistently for little double the engagement about that made the the long, the we we the a reduced the or efforts quarter of but only quarter engagement on coming manifested they’re in commentary

our more expect heavily I create So, information help we’ll continue to we’ll supportive that allows innovative better, to their even that health knowing more are to able even more get from outcomes. and consumers more that products and think them on of them focus being them us

side. not just the on this XXXX a well So this XXXX into engagement will thing, continue is as

Operator

question. One Draper proceed. line you. It comes with our next moment Sandy Partners. Guggenheim of the Thank from Please for

Sandy Draper

been of the have down questions drill A much. pharma last lot just you one on solution Thank side. appreciate manufacturer very the all the Maybe asked and answers.

about was were to recent, you believe comments it maybe I September trying in expecting to or this year. through, double made think still back business even some there a Just at that

while so it’s growing quickly. And still slowed obviously fairly you’re down nicely,

the trying I’m side. you you’re more this some programs average trying it much think just is if think can of versus the tenure about out and facing give how of coming of of What, So, how consumer to long visibility working, like physician around is. just commentary to

think understand, Just the just that it than trying Thanks. but understand quickly, to maybe or market have shorter really customer view turn of long-term visibility, contracts just positive, duration switches concentration it’s off may I unless and I the the that is much how trying to expected?

Karsten Voermann

for it’d thanks to speak question well. This again. Sandy, as be is with great you the Hey Karsten and

about XX%. to is it’s performance we best it man sol’s when the the of of up at think way look I months year, articulate sort for first the pharma’s nine

shy shy doubling. of or somewhat of So just

double earlier we first year. the That to think said close through largely we expected it the nine year I for months. this true to held

I for quarter. the fourth think

delays We’re that’s bit I shifted really seeing environment else. think revenue where see more again, that than was. a something little macro And as a we versus it anything that

where the can deliveries gets out. when course recognize and then the I of also the of other think are delivery pushed And if that the them on aspect delayed, that, revenue them. on is deals you

of but by offerings be time or particular in more double certain offerings they what customer of manufacture In revenue. customer digits, with are do by see is percentage that business any of very and revenue double think let few and leverage episodic we solutions manufacturer others large of to tied very our accounts is or the duration of in business The where few very kinds who them of a deal even made digit solutions minority pharma a But very, for if high majority. of a can dispersion terms them manufacturers anyone on of made alone trying to of it’s a in year. not terms them concentration

historically enrollment the are have fourth example, or that third Medicare For predominantly versus the spend quarter quarter. happens we enrollment, the support entities open to in seeking worked second open Medicare with say quarter

not areas, quarter. do come can you same that but the from in come those see so And in a quarter, in one in subsequent revenue entities

to the at therefore you Q-o-Q is look time, quarter I as apply portfolio the continue business will swing can other a volatility period, issue the of a market that it. anything scale the to of and we particular, see and few hit unique interim revenue business. rate decrease the think quite this while and Jan ask see the like over large timing with associated else that I we piece ability theory a more as will But nature it those ago. go think that individual when be this expand than our given and huge growth, minutes given Q-o-Q continues again, the in it as growth TAM We and deals in as to more

are, the by I of and heard we’re providers sheer that just prescriptions number well, most the on the healthcare folks incredibly we with an given certainly think clearly too, stressing people work one call cases, which haven’t who course, identify as we of past, us and from audience, in can is in by this write. them of attractive the that specialty they

So we consumer coordinated about also them to side providers we given manufacturers, of is benefit that can pharma a using especially huge is in that support having that GoodRx think on talked I the XXX,XXX something that earlier, fashion. healthcare

Operator

with One line moment comes question, from Valiquette for Steve proceed. the It please. Thank Barclays. our of you. next Please

Steve Valiquette

question. everyone Great. taking Thanks afternoon. Hi, good the for

key the August dispute alluded scenario grocers reiterated grocery from Anything, direct such resolved So with just two for you or wanted you relationships as to a this that walk moment. as a positive and was as your through on a to communication call; development. retailers the

their some dispute became XX, think However, I still Scripts XXth little commercial in resolved community themselves a December terminated. by their contract that was September a the and not bit confused and back announced would Kroger resolution investment when, without between on Express the be

the to mitigate trying the brochures So, GoodRx release clarity now that your PBM Express terminated Just what from around get XX [indiscernible] mentioned? that scenario I shield or Scripts. be is XX/XX/XX, just either Express your you does that that that, or impact either I press does Thanks. And you new with any. Scripts, or then if September that from XXXX, collaboration expected shield if with Kroger/Express scenario really would contract question Kroger is, on contracts in guess Scripts direct

Doug Hirsch

you between very thank Kroger business. not, Scripts, would our don’t the that Express and we affect Yes, question. much anything for I’m anticipate

been As with at we discounts I welcome been going mentioned our relationships, we’ve GoodRx pharmas view at GoodRx What are highlight guess, U.S. again, almost to like that I’d addressed the Kroger. we We’ve grocer that seeing. strengthening how all been incredibly is as we’ve because forth issue and accepted in pleased the We important. retail growth

a ensure We’re us various with the selectively solutions. of including let stability collaborate growing of that relationships these on lets many model number contracting direct chains and largest as direct us hybrid network pharmacies, a

relationships, together. has us to led initiatives continued work on of All this strategic of those have strengthening led

traffics driving We’re to locations. retailer

merchandise adherence. we’re getting spend are for, in We’re driving their additional additional customers for we’re their there’s driving who in places, pharmacy, not stores to using them use pharmacies,

additional all driving we’re So, benefits. these

been our to know just have economics, And I that that margins. also, strength mentioned, for improve against direct as relationships be balancing to as these partially while partnerships continue effort also will of which up We’re you for to good making we unit open hybrid the these opportunities as strong by headways evidenced strong incremental. our think stickier own be this economics retailers

we further. So, have we’re that we think may strengthen really this pleased

retail retail additional the hope Eagle network, which such question? adds to addition geographical to network, additions gold I new the the seeing also answers that coverage. We’re the Giant as of And

Operator

Wells next Berenshteyn the question. Thank Please Stan ahead. go moment with One for our you. of line from Fargo. comes It

Stan Berenshteyn

much Hi, thanks questions. taking for so for my

And have renewal? we’re up us maybe Thanks you sunset that walk as Savings can is through year, you the can much. for so the Club next when thinking in remind maybe revenue Kroger contract [ph]? the So, visibility about contract the event is you us

Karsten Voermann

to Stan, great Karsten Sure. with speak you. here.

think earnings the our we of make, the a proportion small, Kroger to that talked that calls very as scale revenue. revenue. And a Savings of that proportion is proportion to our couple Club a we support of the couple about I as subscription reality and our our points Club of revenue Savings ago both the is total Kroger subscriptions

the right to run agreement shed new plans. own And majority our So current from wanted with July of through from light XXXX. that That perspective that enrolling said of subscription massive comes the program. Gold now we’re on Kroger the really annual revenue fact members our on

XXXX past Of this July at course, we’re point. of

needle extremely line we’re available overall, are in But is availability good at add members a one, So, business, the think I this own Number Kroger doesn’t through the on response to ago plan point. said that think Kroger that another I they ESI GoodRx of with the on though, at us used relationship as relative mid-XXXX the servicing of by at question, indicator at to again Kroger. if, especially KSC. Steve pleased two, we’re as all minutes welcomed I needle working the annual nature GoodRx ubiquity now discounts is is GoodRx question, that the that few or offerings our I that, Having us least again, think given that’s key. business of and a earlier really them available we’re that’s be. move of got still asked KSC for other pleased Number that especially too. as and our continuing to to Kroger to And swing extremely bottom is critical, with aren’t

Operator

comes moment the question, from it of for with Schoenhaus Thank And you. One please. next KeyBanc. our Scott line

Scott Schoenhaus

on mode up team. Hi the I last month with EHR. wanted that launched provider combined follow to the

clients you this pharma translate what do growing pharma partnering this said versus price this you’re does your manufacturing the differently You stream? revenue manufacturing Is into XXXX with. Thanks. How and for into your see legacy growth?

Doug Hirsch

we’re it’s valuable we to When we’re look bit maybe what and generally how about it. mode with at monetizing going – and Sure. doing provider we a I’m think I’ll speak why

so actively providers XXX,XXX our HCPs So GoodRx is talking GoodEx healthcare and have providers, of GoodRx about, offerings is and provider offices mode materials. mode, providers, been for we general we’ve distribute these from this including more flipMD GoodRx GoodRx provider part work all of HCP with than

last technology help get is advantages that and be through and HCP parties to mode a a journey, related the provider to it to month number platform this So number consumers, adherence we get advantages medication. of access help medication, and healthcare of provides launched has patients

solutions access advantages faster, in prescribers really include patients the mode mode including office front synergistic also all through get the to discount manufacturer get help patients the and all with them. and medications, pharma provider it both more the to this users increased to across of their a monetized provider assistants nurses, customized And business, discounts brands, get use our are providers super get and prescription get access solutions. and to pharma because gives business patients prescription is HCPs, redesigned specialty participants medical This gets gets help of one helping savings these that important we’ve expanded we’re through This trying to their flow right is prescription medication. to the of manufacturer monetized So experience staff, all from generic solutions.

manufacturer other both then deals, have your and an consumer deal, for that part our offerings. believe solutions are question of pharma HCP of example. is HCP our are Some And we for this specifically deals I

Operator

go please. comes next Please D.A. of One Davidson. our Thank line the with you. Simmons from ahead. moment question, Robert It for

Robert Simmons

the taking Hey guys, for thanks question.

that a you the understandable So and they’re on going start it’s quarter-over-quarter basis? go do number but up plans again think will to down of subscription trough expected now, and when

Doug Hirsch

Yes, for the thank you question.

grew XX% subscription So $XX.X quarter. the million revenue for year-over-year to

I As to focus has we’ve patient discussed, chronic the to believe program continue and that sort chronic – and care of has to expectations the increase price worked. conditions on we sort the work decision optimizing And it of that the, expected with than of chronic within there, are people that tighten as with we to we’ve but of tightly. made or the take amount been focus patients, decreasing better our the more, more it.

again. you’ll increasing so and a program start to subscriber that continued there broader of some numbers set see users broader And as make try improvements and applicable we

Operator

our Thank from comes moment line for Please It One the of next UBS. proceed. Kevin please. with Caliendo question, you.

Kevin Caliendo

Thanks and it? make the you. rate, of to forward, driver how and working should run I’m software? this accelerate we or I for investments about is model it if higher in year. Thank in going to number than off the continue of Just jumped in. thinking getting this XQ you to the that last noticed run rate going be software as year wondering lot the capitalized is is me a just

Doug Hirsch

Sure.

question. thanks So for the great

of work managing I on terms in code, new delivering cap continue us year’s focus drive Kevin offerings infrastructure we and all, our focus capitalization of of on and little to consumers talked to the to now we Head direct as to heavily continuing base too. we’re over And better. prior about products serve faster function for and time a new new consumers, that’s really that’s spent First initiatives seeing done that crept what has we Hall develop you’re healthcare value taking And us as features, up in rate like offerings Trevor creating mode like new we’re, things focused soft that, a allow to the and being to new just lot through these building on to since product, think Mark do maintaining a on the a very consumers great other hard particularly joined the, provider the seeing, of which of you’re very, bit. shift and very providers

Karsten Voermann

particular there And, focused on this adjusted efficient is And are yes, what I us expansion. laser EBITDA. expectations want growth margin exceed quarter, in to we what series driving and on though just to enabled of taking highlight actions we’ve the is driving been

did I in ourselves. reduction in fourth complete to on realignment, the things We organizational two want So the rely highlight. August to

some, quickly. had are we executed in hard that the getting that well and even believe While now tradeoffs, out operating effectively door more we that was products it’s very

also QX We efficiency. maintaining on advertising have and stable relatively reduced heading good marketing spend really max. headway We’ve while made into

really GoodRx this there done just opportunities this, made really spending. is us and the that need we solutions, And is The a is we the can is continue there to final macro as for. shines. comment see employers showed So be then affordability as environment some affordability we efficient And where cut what strength work has increasing consumers back GoodRx there. our solid more need and brand only for really this being of my

to these We help consumers them their are to to outcomes. medications health medications to need really better get keep harder in times to people here, slightly adherent they the produce

that. provide you. we happy we’re Thank can So

Operator

gentlemen, ladies participating the now program for thank that, Thank with Q&A today. and you and conclude And disconnect. may for and you. you. Thank We you we

GoodRx (GDRX) 9 Nov 222022 Q3 Earnings call transcript